Gene: NELL2
Official Full Name: neural EGFL like 2provided by HGNC
Gene Summary: The protein encoded by this gene is a glycoprotein containing several von Willebrand factor C domains and epidermal growth factor (EGF)-like domains. The encoded protein acts as a homotrimer and is found in the cytoplasm. Several variants encoding a few different isoforms exist, and at least one isoform appears to be a secreted protein. Studies in mouse suggest that this protein plays a role in neural cell growth and differentiation as well as in oncogenesis. [provided by RefSeq, Feb 2009]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO02417 | NELL2 Knockout cell line (HeLa) | Human | NELL2 | 1:3~1:6 | Negative | Online Inquiry |
KO02418 | NELL2 Knockout cell line (HEK293) | Human | NELL2 | 1:3~1:6 | Negative | Online Inquiry |
NELL2 Gene Knockout Cell Lines are specialized cellular models engineered to lack the expression of the NELL2 gene, a critical influencer of neuronal survival and plasticity. Developed through precise gene-editing techniques such as CRISPR/Cas9, these cell lines allow for the in-depth study of NELL2's role in neurobiology and its implications in various neurodegenerative diseases.
These knockout cell lines function by providing a definitive platform for examining the downstream effects of NELL2 loss. Researchers can investigate alternative signaling pathways activated in its absence, offering insights into compensatory mechanisms in neuronal health. By utilizing these models, scientists can explore the impacts of NELL2 depletion on cellular processes such as apoptosis, synaptic integrity, and neuroinflammation.
From a scientific perspective, NELL2 Gene Knockout Cell Lines hold immense importance in both research and clinical settings. They enable the elucidation of pathophysiological mechanisms underlying conditions like Alzheimer's disease and amyotrophic lateral sclerosis. Moreover, these models facilitate drug discovery by allowing the screening of compounds that might restore normal cellular function in NELL2-deficient contexts.
Compared to alternative models, such as conventional wild-type cells or less specific knockdown approaches, the NELL2 Gene Knockout Cell Lines offer a more precise and thorough understanding of genetic function. Their specific genetic alteration leads to unequivocal effects on cellular behavior, thus providing reliable data critical for experimental reproducibility.
For researchers and clinicians seeking innovative solutions to advance their understanding of neurobiological processes and develop therapeutic interventions, NELL2 Gene Knockout Cell Lines represent a valuable asset. The ability to explore the gene’s distinct roles brings unparalleled clarity to the complexities of neuronal biology.
Backed by our company's extensive expertise in generating robust biological models, the NELL2 Gene Knockout Cell Lines are equipped with the reliability and specificity necessary to support groundbreaking research in neuroscience.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.